Pathology and cellular kinetics of gallbladder with an anomalous junction of the pancreaticobiliary duct

American Journal of Gastroenterology

Volumn 91, Issue 5, 1996, Pages 1007-1011

  Hanada, Keiji ^a   Itoh, Masaki ^a   Fujii, Kiyomu ^a   Tsuchida, Akira ^a   Hirata, Manabu ^a   Ishimaru, Shouhei ^a   Iwao, Toshiyasu ^a   Eguchi, Noriaki ^a   Kajiyama, Goro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE DUCT; CANCER RISK; CELL KINETICS; GALLBLADDER CARCINOMA; GALLBLADDER DISEASE; GALLBLADDER MUCOSA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABELING INDEX; PANCREAS DUCT; PRIORITY JOURNAL; RISK ASSESSMENT; TISSUE SECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BILE DUCTS; CELL CYCLE; CHILD; CHILD, PRESCHOOL; GALLBLADDER; GALLBLADDER NEOPLASMS; HUMANS; HYPERPLASIA; INFANT; METAPLASIA; MIDDLE AGED; MUCOUS MEMBRANE; PANCREATIC DUCTS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0029901357     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Komi N, Udaka H, Ikeda N, et al. Congenital dilatation of the biliary tracts: New classification and study with particular reference to anomalous arrangement of the pancreaticobiliary ducts. Gastroenterol Jpn 1977;12:293-304.
2. Kimura K, Ohto M, Saisho H, et al. Association of gallbladder carcinoma and an anomalous pancreaticobiliary duct union. Gastroenterology 1985;89:1258-65.
3. Kinoshita H, Nagata E, Hirohashi K, et al. Carcinoma of the gallbladder with an anomalous connection between the choledochus and the pancreatic duct. Cancer 1984;54:762-9.
4. Ohta T, Nagakawa T, Ueno K, et al. Clinical experience of biliary tract carcinoma associated with anomalous union of the pancreaticobiliary ductal system. Jpn J Surg 1990;20:36-43.
5. Todani T, Watanabe Y, Fujii T, et al. Anomalous arrangement of the pancreaticobiliary ductal system in patients with a choledochal cyst. Am J Surg 1984;147:672-6.
6. Yamauchi S, Koga A, Matsumoto S, et al. Anomalous junction of pancreaticobiliary duct without congenital choledochal cyst: A possible risk factor for gallbladder cancer. Am J Gastroenterol 1987;82: 20-4.
7. Beahrs OH, Henson DE, Hutter RVP, et al., eds. Manual for staging of cancer, 4th ed. Philadelphia: JB Lippincott, 1992.
8. Yamamoto M, Nakajo S, Tahara E, et al. Mucosal changes of the gallbladder in anomalous union with the pancreatico-biliary duct system. Pathol Res Pract 1991;187:241-6.
9. Babbit DP. Congenital choledochal cyst: New etiological concept based on anomalous relationships of the common bile duct and pancreatic bulb. Ann Radiol 1969;12:231-40.
10. Shimada K, Yanagisawa J, Nakayama F. Increased lysophosphatidylcholine and pancreatic enzyme content in bile of patients with anomalous pancreaticobiliary ductal junction. Hepatology 1991;13:438-44.
11. Ito M. Lysophosphatidylcholine in the bile of patients with choledocholithiäsis, anomalous union of the pancreatico-biliary ductal system, intrahepatic gallstones and bile duct carcinoma. J Jpn Biliary Assoc 1993;7:491-8 (in Japanese with English abstract).
12. Yamamoto M, Nakajo S, Tahara E. Dysplasia of the gallbladder. Its histogenesis and correlation to gallbladder adenocarcinoma. Pathol Res Pract 1989;185:454-60.
13. Kozuka S, Kurashina M, Tsubone M, et al. Significance of intestinal metaplasia for the evolution of cancer in biliary tract. Cancer 1984; 54:2277-85.
14. Nagata E, Sakai K, Kinoshita H, et al. The relation between carcinoma of the gallbladder and an anomalous connection between the choledochus and the pancreatic duct. Ann Surg 1985;202:182-90.
15. Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues: Comparison with flow cytometric analysis. Am J Pathol 1989; 134:733-9.
16. Kamel OW, LeBrun DP, Davis RE, et al. Growth fraction estimation of malignant lymphomas in formalin-fixed, paraffin-embedded tissue using anti-PCNA/cyclin 19A2: Correlation with Ki67 labeling. Am J Pathol 1991;138:1471-7.
17. Hanada K, Itoh M, Fujii K, et al. Expression of the proliferative cell nuclear antigen (PCNA) in adenocarcinoma of the gallbladder and its relationship to prognosis. Scand J Clin Lab Invest 1995;55:377-82.
18. Tokiwa K, Iwai N, Nakamura K, et al. Gallbladder mucosa ornithine decarboxylase activity is increased in patients with anomalous arrangement of the pancreaticobiliary duct. Cancer 1992;69:2440-3.
19. Rene BM, George AH, Jesse LB, et al. Intraductal pressures and sphincteric resistance in canine pancreatic and biliary ducts after various stimuli. Surg Gynecol Obstet 1958;106:306-20.
20. Shimada K, Yanagisawa J, Nakayama F. Increased lysophosphatidylcholine and pancreatic enzyme content in bile of patients with anomalous pancreaticobiliary ductal junction. Hepatology 1991;13:438-44.
21. 2 stimulates the growth of human pancreatic cancer cell line. FEBS Lett 1995;373:85-7.
22. 2 in Swiss 3T3 cells via specific binding site. J Biol Chem 1991;266:19139-41.
23. 2 in the rat. J Biol Chem 1992;267: 6414-20.